RPAM
Rhenman & Partners Asset Management’s Procept Biorobotics PRCT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.9M | Sell |
190,000
-258,000
| -58% | -$14.9M | 1.38% | 29 |
|
|
2025
Q1 | $26.1M | Buy |
448,000
+27,655
| +7% | +$1.61M | 3% | 8 |
|
|
2024
Q4 | $33.8M | Sell |
420,345
-24,655
| -6% | -$1.99M | 3.48% | 3 |
|
|
2024
Q3 | $35.7M | Buy |
445,000
+5,000
| +1% | +$401K | 2.89% | 6 |
|
|
2024
Q2 | $26.9M | Sell |
440,000
-47,063
| -10% | -$2.88M | 2.58% | 11 |
|
|
2024
Q1 | $24.1M | Buy |
487,063
+177,063
| +57% | +$8.75M | 2.28% | 14 |
|
|
2023
Q4 | $13M | Sell |
310,000
-183,000
| -37% | -$7.67M | 1.3% | 29 |
|
|
2023
Q3 | $16.2M | Buy |
493,000
+214,000
| +77% | +$7.02M | 1.74% | 24 |
|
|
2023
Q2 | $9.86M | Buy |
+279,000
| New | +$9.86M | 1.04% | 35 |
|